GB0723748D0 - Therapeutic agents - Google Patents
Therapeutic agentsInfo
- Publication number
- GB0723748D0 GB0723748D0 GBGB0723748.0A GB0723748A GB0723748D0 GB 0723748 D0 GB0723748 D0 GB 0723748D0 GB 0723748 A GB0723748 A GB 0723748A GB 0723748 D0 GB0723748 D0 GB 0723748D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- therapeutic agents
- therapeutic
- agents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0723748.0A GB0723748D0 (en) | 2007-12-04 | 2007-12-04 | Therapeutic agents |
PCT/GB2008/004011 WO2009071895A1 (en) | 2007-12-04 | 2008-12-03 | Fused thiazole and thiophene derivatives as kinase inhibitors |
PCT/GB2008/004018 WO2009071901A1 (en) | 2007-12-04 | 2008-12-03 | A substituted thieno-pyridinone kinase inhibitor |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0723748.0A GB0723748D0 (en) | 2007-12-04 | 2007-12-04 | Therapeutic agents |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0723748D0 true GB0723748D0 (en) | 2008-01-16 |
Family
ID=38982993
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0723748.0A Ceased GB0723748D0 (en) | 2007-12-04 | 2007-12-04 | Therapeutic agents |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0723748D0 (en) |
WO (1) | WO2009071901A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI378933B (en) | 2008-10-14 | 2012-12-11 | Daiichi Sankyo Co Ltd | Morpholinopurine derivatives |
LT3230289T (en) | 2014-12-11 | 2019-10-10 | Natco Pharma Limited | 7-(morpholinyl)-2-(n-piperazinyl) methyl thieno [2, 3-c]pyridine derivatives as anticancer drugs |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2402347A1 (en) * | 2006-04-26 | 2012-01-04 | F. Hoffmann-La Roche AG | Pharmaceutical compounds |
GB0611152D0 (en) * | 2006-06-06 | 2006-07-19 | Ucb Sa | Therapeutic agents |
-
2007
- 2007-12-04 GB GBGB0723748.0A patent/GB0723748D0/en not_active Ceased
-
2008
- 2008-12-03 WO PCT/GB2008/004018 patent/WO2009071901A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2009071901A1 (en) | 2009-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2117311A4 (en) | Therapeutic agents | |
GB0811304D0 (en) | Therapeutic agents | |
GB0609492D0 (en) | Therapeutic agents | |
HRP20130041T8 (en) | Therapeutic agents | |
GB0608928D0 (en) | Therapeutic agents | |
GB0601962D0 (en) | Therapeutic agents | |
GB0811643D0 (en) | New therapeutic agents | |
GB0616214D0 (en) | Therapeutic Agents | |
GB0819593D0 (en) | Therapeutic agents | |
GB0723747D0 (en) | Therapeutic agents | |
GB0821693D0 (en) | Therapeutic agents | |
GB0611152D0 (en) | Therapeutic agents | |
GB0812309D0 (en) | Therapeutic agents | |
GB0805818D0 (en) | Therapeutic agents | |
GB0801081D0 (en) | Therapeutic agents | |
GB0801080D0 (en) | Therapeutic agents | |
GB0724340D0 (en) | Novel Therapeutic Agents | |
GB0620818D0 (en) | Therapeutic agents | |
GB0620059D0 (en) | Therapeutic agents | |
GB0609676D0 (en) | Therapeutic agents | |
EP2140876A4 (en) | Therapeutic agent comprising vasohibin | |
GB0723748D0 (en) | Therapeutic agents | |
EP2454276A4 (en) | Therapeutic agents | |
GB0808690D0 (en) | Therapeutic use | |
GB0622195D0 (en) | Therapeutic agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |